AUROPHARMA Intraday Analysis...

AUROPHARMA Share Price

Open 611.10 Change Price %
High 621.85 1 Day -3.55 -0.58
Low 601.85 1 Week -6.30 -1.03
Close 607.55 1 Month 13.40 2.26
Volume 2568910 1 Year -64.70 -9.62
52 Week High 809.45
52 Week Low 527.00
AUROPHARMA Important Levels
Resistance 2 626.09
Resistance 1 618.45
Pivot 610.42
Support 1 596.65
Support 2 589.01
NSE INDIA Most Active Stocks
JPASSOCIAT 17.45 1.16%
RCOM 14.65 -0.34%
VEDL 230.65 0.92%
SUZLON 7.85 1.95%
IDEA 56.00 -7.51%
GMRINFRA 15.95 -0.31%
IDBI 58.00 -1.53%
PNB 79.80 -2.56%
VAKRANGEE 55.10 4.95%
TATAMOTORS 289.40 -6.04%
More..
NSE INDIA Top Gainers Stocks
PRAKASHSTL 0.10 100.00%
MVL 0.30 20.00%
MVL 0.30 20.00%
GALLISPAT 289.75 15.92%
AMJLAND 28.00 15.23%
PNBHOUSING 1221.55 13.89%
RAMKY 187.45 12.31%
TRF 224.15 11.82%
TRF 224.15 11.82%
MAHSCOOTER 3219.15 11.40%
More..
NSE INDIA Top Losers Stocks
UNIPLY 80.75 -80.54%
KSERASERA 0.15 -25.00%
RAJRAYON 0.20 -20.00%
KRBL 375.00 -19.98%
JVLAGRO 13.90 -19.88%
SPYL 0.30 -14.29%
STEELXIND 15.15 -13.18%
SUJANAUNI 0.50 -9.09%
SRSLTD 0.50 -9.09%
SHYAMTEL 12.00 -9.09%
More..

Aurobindo Pharma Limited (NSE: AUROPHARMA)

AUROPHARMA Technical Analysis 1.5
As on 25th Jun 2018 AUROPHARMA Share Price closed @ 607.55 and we RECOMMEND Sell for LONG-TERM with Stoploss of 663.44 & Buy for SHORT-TERM with Stoploss of 599.91 we also expect STOCK to react on Following IMPORTANT LEVELS.
AUROPHARMA Target for June
1st Target up-side 606.88
2nd Target up-side 642.33
3rd Target up-side 677.78
1st Target down-side 505.72
2nd Target down-side 470.27
3rd Target down-side 434.82
AUROPHARMA Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 56.10 Sideways
MFI (14) MFI is Above 80 Over Bought
CCI (20) CCI is 78.63 Sideways
WILLIAM %R (14) William %R is -20.33 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 581.99
10 Day Avg Volume Traded -23.02 % Less then 10 Day Average Volume
AUROPHARMA Other Details
Segment EQ
Market Capital 25150871552.00
Sector Pharmaceuticals
Industry
Offical website
AUROPHARMA Address
AUROPHARMA
N/A
AUROPHARMA Latest News
Interactive Technical Analysis Chart Aurobindo Pharma Limited ( AUROPHARMA NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Aurobindo Pharma Limited
AUROPHARMA Business Profile
Aurobindo Pharm is in the Pharmaceuticals sector. Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India. The current market capitalisation stands at Rs 8,284.96 crore.The company has reported a consolidated sales of Rs 1913.86 crore and a Net Profit of Rs 233.86 crore for the quarter ended Sep 2013. The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, P Sarath Chandra Reddy - Non Executive Director, M Sitarama Murthy - Non Executive Director, D Rajagopala Reddy - Non Executive Director, C Channa Reddy - Non Executive Director. It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA. Its Registered office is at Plot No. 2, Maitrivihar,,Ameerpet Hyderabad,Andhra Pradesh - 500038.